Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

GSK Operating Income 2010-2024 | GSK

GSK annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • GSK operating income for the quarter ending September 30, 2024 was $0.246B, a 90.04% decline year-over-year.
  • GSK operating income for the twelve months ending September 30, 2024 was $4.926B, a 45.97% decline year-over-year.
  • GSK annual operating income for 2023 was $8.39B, a 5.44% increase from 2022.
  • GSK annual operating income for 2022 was $7.957B, a 6.68% decline from 2021.
  • GSK annual operating income for 2021 was $8.527B, a 14.67% decline from 2020.
  
GSK Annual Operating Income
(Millions of US $)
2023 $8,390
2022 $7,957
2021 $8,527
2020 $9,993
2019 $8,889
2018 $7,319
2017 $5,267
2016 $3,521
2015 $15,782
2014 $5,417
2013 $10,392
2012 $11,717
2011 $12,526
2010 $5,850
2009 $13,193
GSK Quarterly Operating Income
(Millions of US $)
2024-09-30 $246
2024-06-30 $2,077
2024-03-31 $1,889
2023-12-31 $713
2023-09-30 $2,467
2023-06-30 $2,681
2023-03-31 $2,529
2022-12-31 $1,439
2022-09-30 $1,403
2022-06-30 $1,357
2022-03-31 $3,758
2021-12-31 $1,179
2021-09-30 $2,672
2021-06-30 $2,341
2021-03-31 $2,335
2020-12-31 $1,477
2020-09-30 $2,400
2020-06-30 $3,537
2020-03-31 $2,580
2019-12-31 $2,473
2019-09-30 $2,647
2019-06-30 $1,908
2019-03-31 $1,860
2018-12-31 $1,368
2018-09-30 $2,489
2018-06-30 $1,060
2018-03-31 $2,401
2017-12-31 $707
2017-09-30 $2,457
2017-06-30 $-26
2017-03-31 $2,128
2016-12-31 $740
2016-09-30 $1,879
2016-06-30 $-217
2016-03-31 $1,036
2015-12-31 $13,361
2015-09-30 $1,434
2015-06-30 $420
2015-03-31 $636
2014-12-31 $-57
2014-09-30 $1,358
2014-06-30 $1,754
2014-03-31 $1,798
2013-12-31 $3,669
2013-09-30 $2,714
2013-06-30 $2,159
2013-03-31 $2,168
2012-12-31 $3,566
2012-09-30 $2,853
2012-06-30 $2,621
2012-03-31 $3,002
2011-12-31 $3,723
2011-09-30 $3,115
2011-06-30 $2,783
2011-03-31 $2,752
2010-12-31 $-270
2010-09-30 $3,036
2010-06-30 $-1,208
2010-03-31 $3,068
2009-12-31 $4,080
2009-09-30 $3,402
2009-06-30 $3,480
2009-03-31 $2,384
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $70.529B $37.714B
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $142.172B 13.76
Bristol Myers Squibb (BMY) United States $117.147B 49.37
Gilead Sciences (GILD) United States $117.087B 21.21
Vertex Pharmaceuticals (VRTX) United States $105.118B 0.00
CSL (CSLLY) Australia $85.947B 0.00
Regeneron Pharmaceuticals (REGN) United States $78.513B 17.87
Argenex SE (ARGX) Netherlands $38.031B 0.00
Alnylam Pharmaceuticals (ALNY) United States $31.375B 0.00
BioNTech SE (BNTX) Germany $27.362B 0.00
Biogen (BIIB) United States $21.715B 9.33
Illumina (ILMN) United States $21.444B 78.16
BeiGene (BGNE) Cayman Islands $17.711B 0.00
Moderna (MRNA) United States $15.497B 0.00
Genmab (GMAB) Denmark $13.546B 19.87
Incyte (INCY) United States $13.468B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.699B 29.48
Insmed (INSM) United States $12.618B 0.00
Sarepta Therapeutics (SRPT) United States $11.644B 105.09
Bio-Techne Corp (TECH) United States $11.604B 44.80
Exact Sciences (EXAS) United States $10.755B 0.00
Vaxcyte (PCVX) United States $10.708B 0.00
QIAGEN (QGEN) Netherlands $10.283B 21.16
Swedish Orphan Biovitrum (BIOVF) Sweden $9.847B 40.68
Exelixis (EXEL) United States $9.658B 21.96
Bio-Rad Laboratories (BIO.B) United States $9.123B 31.00
Intra-Cellular Therapies (ITCI) United States $9.037B 0.00
Roivant Sciences (ROIV) United Kingdom $8.735B 0.00
Ascendis Pharma (ASND) Denmark $8.422B 0.00
Repligen (RGEN) United States $8.233B 107.26
Jazz Pharmaceuticals (JAZZ) Ireland $7.480B 7.32
Revolution Medicines (RVMD) United States $7.467B 0.00
Halozyme Therapeutics (HALO) United States $6.048B 13.66
Legend Biotech (LEGN) United States $5.990B 0.00
Nuvalent (NUVL) United States $5.872B 0.00
Blueprint Medicines (BPMC) United States $5.747B 0.00
Cytokinetics (CYTK) United States $5.727B 0.00
Telix Pharmaceuticals (TLX) Australia $5.315B 0.00
TG Therapeutics (TGTX) United States $5.006B 0.00
Alkermes (ALKS) Ireland $4.797B 16.11
Viking Therapeutics (VKTX) United States $4.719B 0.00
Krystal Biotech (KRYS) United States $4.559B 75.49
Scholar Rock Holding (SRRK) United States $4.265B 0.00
Axsome Therapeutics (AXSM) United States $4.217B 0.00
Arcellx (ACLX) United States $4.195B 0.00
Apellis Pharmaceuticals (APLS) United States $4.145B 0.00
ADMA Biologics Inc (ADMA) United States $4.116B 43.53
Ultragenyx Pharmaceutical (RARE) United States $4.040B 0.00
Guardant Health (GH) United States $3.901B 0.00
Immunovant (IMVT) United States $3.828B 0.00
Alvotech (ALVO) Luxembourg $3.787B 0.00
Avidity Biosciences (RNA) United States $3.740B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.659B 0.00
Biohaven (BHVN) United States $3.615B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.494B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.432B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.366B 0.00
NovoCure (NVCR) Jersey $3.351B 0.00
Denali Therapeutics (DNLI) United States $3.011B 0.00
Janux Therapeutics (JANX) United States $2.946B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.929B 0.00
Amicus Therapeutics (FOLD) United States $2.925B 0.00
Zai Lab (ZLAB) China $2.921B 0.00
Merus (MRUS) Netherlands $2.904B 0.00
Twist Bioscience (TWST) United States $2.903B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.840B 21.89
Vericel (VCEL) United States $2.829B 955.17
Edgewise Therapeutics (EWTX) United States $2.805B 0.00
SpringWorks Therapeutics (SWTX) United States $2.738B 0.00
Vera Therapeutics (VERA) United States $2.655B 0.00
Kymera Therapeutics (KYMR) United States $2.644B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.493B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.443B 0.00
Beam Therapeutics (BEAM) United States $2.386B 0.00
Protagonist Therapeutics (PTGX) United States $2.342B 14.77
Iovance Biotherapeutics (IOVA) United States $2.283B 0.00
NeoGenomics (NEO) United States $2.201B 0.00
IDEAYA Biosciences (IDYA) United States $2.187B 0.00
CG Oncology (CGON) United States $2.152B 0.00
Ligand Pharmaceuticals (LGND) United States $2.142B 53.48
Apogee Therapeutics (APGE) United States $2.131B 0.00
Tarsus Pharmaceuticals (TARS) United States $2.066B 0.00
Bavarian Nordic (BVNRY) Denmark $2.062B 12.64
WAVE Life Sciences (WVE) Singapore $2.045B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.024B 0.00
Geron (GERN) United States $2.019B 0.00
Akero Therapeutics (AKRO) United States $1.993B 0.00
Agios Pharmaceuticals (AGIO) United States $1.950B 0.00
Mesoblast (MESO) Australia $1.943B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.942B 16.14
Disc Medicine (IRON) United States $1.935B 0.00
Belite Bio (BLTE) United States $1.915B 0.00
MannKind (MNKD) United States $1.859B 48.14
ImmunityBio (IBRX) United States $1.833B 0.00
Galapagos (GLPG) Belgium $1.793B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.755B 0.00
Certara (CERT) United States $1.723B 48.64
Neumora Therapeutics (NMRA) United States $1.717B 0.00
Dynavax Technologies (DVAX) United States $1.688B 98.77
Fortrea Holdings (FTRE) United States $1.682B 53.57
Celldex Therapeutics (CLDX) United States $1.667B 0.00
Structure Therapeutics (GPCR) United States $1.618B 0.00
Viridian Therapeutics (VRDN) United States $1.530B 0.00
Arcus Biosciences (RCUS) United States $1.456B 0.00
Praxis Precision Medicines (PRAX) United States $1.440B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.440B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.434B 0.00
Nurix Therapeutics (NRIX) United States $1.386B 0.00
Novavax (NVAX) United States $1.363B 0.00
MiMedx (MDXG) United States $1.342B 35.12
Travere Therapeutics (TVTX) United States $1.337B 0.00
Arvinas (ARVN) United States $1.287B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.278B 0.00
Myriad Genetics (MYGN) United States $1.251B 0.00
Intellia Therapeutics (NTLA) United States $1.227B 0.00
Spyre Therapeutics (SYRE) United States $1.200B 0.00
Septerna (SEPN) United States $1.150B 0.00
ANI Pharmaceuticals (ANIP) United States $1.139B 15.52
Syndax Pharmaceuticals (SNDX) United States $1.116B 0.00
Gyre Therapeutics (GYRE) United States $1.113B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.065B 0.00
Bicara Therapeutics (BCAX) United States $1.040B 0.00
Upstream Bio (UPB) United States $1.040B 0.00
Vir Biotechnology (VIR) United States $1.016B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.014B 0.00
Liquidia Technologies (LQDA) United States $0.976B 0.00
Zymeworks (ZYME) United States $0.974B 0.00
Nuvation Bio (NUVB) United States $0.949B 0.00
Adaptive Biotechnologies (ADPT) United States $0.943B 0.00
Poseida Therapeutics (PSTX) United States $0.928B 0.00
Anavex Life Sciences (AVXL) United States $0.922B 0.00
Pacira BioSciences (PCRX) United States $0.899B 8.47
ArriVent BioPharma (AVBP) United States $0.897B 0.00
AbCellera Biologics (ABCL) Canada $0.871B 0.00
Cogent Biosciences (COGT) United States $0.868B 0.00
LENZ Therapeutics (LENZ) United States $0.866B 0.00
Replimune (REPL) United States $0.855B 0.00
Immatics (IMTX) Germany $0.847B 0.00
UniQure (QURE) Netherlands $0.846B 0.00
89BIO (ETNB) United States $0.843B 0.00
Cytek Biosciences (CTKB) United States $0.836B 0.00
Prothena (PRTA) Ireland $0.829B 0.00
Pliant Therapeutics (PLRX) United States $0.821B 0.00
Avid Bioservices (CDMO) United States $0.784B 0.00
Castle Biosciences (CSTL) United States $0.776B 138.60
Tectonic Therapeutic (TECX) United States $0.746B 0.00
Erasca (ERAS) United States $0.727B 0.00
MBX Biosciences (MBX) United States $0.720B 0.00
Pharming Group (PHAR) Netherlands $0.716B 0.00
Cullinan Therapeutics (CGEM) United States $0.714B 0.00
Tyra Biosciences (TYRA) United States $0.713B 0.00
Kura Oncology (KURA) United States $0.689B 0.00
Oculis Holding AG (OCS) Switzerland $0.688B 0.00
Immunome (IMNM) United States $0.688B 0.00
Dianthus Therapeutics (DNTH) United States $0.678B 0.00
Keros Therapeutics (KROS) United States $0.677B 0.00
Rapport Therapeutics (RAPP) United States $0.675B 0.00
CARGO Therapeutics (CRGX) United States $0.675B 0.00
CureVac (CVAC) Germany $0.669B 5.44
Entrada Therapeutics (TRDA) United States $0.657B 11.04
Sinovac Biotech (SVA) China $0.645B 0.00
Mineralys Therapeutics (MLYS) United States $0.637B 0.00
GRAIL (GRAL) United States $0.632B 0.00
Arbutus Biopharma (ABUS) United States $0.603B 0.00
Stoke Therapeutics (STOK) United States $0.600B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.599B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.591B 0.00
Oric Pharmaceuticals (ORIC) United States $0.578B 0.00
Humacyte (HUMA) United States $0.568B 0.00
Annexon (ANNX) United States $0.557B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.539B 0.00
Astria Therapeutics (ATXS) United States $0.538B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.537B 0.00
Sangamo Therapeutics (SGMO) United States $0.522B 0.00
Kodiak Sciences (KOD) United States $0.519B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.513B 0.00
CorMedix Inc (CRMD) United States $0.505B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.500B 0.00
Terns Pharmaceuticals (TERN) United States $0.493B 0.00
MeiraGTx Holdings (MGTX) United States $0.482B 0.00
Abivax SA (ABVX) France $0.481B 0.00
PureTech Health (PRTC) United States $0.477B 0.00
Cartesian Therapeutics (RNAC) United States $0.469B 0.00
Celcuity (CELC) United States $0.465B 0.00
Third Harmonic Bio (THRD) United States $0.465B 0.00
Alpha Teknova (TKNO) United States $0.458B 0.00
Emergent Biosolutions (EBS) United States $0.450B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.448B 0.00
Allogene Therapeutics (ALLO) United States $0.438B 0.00
MaxCyte (MXCT) United States $0.434B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.433B 0.00
AnaptysBio (ANAB) United States $0.423B 0.00
ChromaDex (CDXC) United States $0.416B 544.00
Aura Biosciences (AURA) United States $0.411B 0.00
Zenas BioPharma (ZBIO) United States $0.407B 0.00
Codexis (CDXS) United States $0.407B 0.00
Sana Biotechnology (SANA) United States $0.391B 0.00
IGM Biosciences (IGMS) United States $0.381B 0.00
Alumis (ALMS) United States $0.380B 0.00
Contineum Therapeutics (CTNM) United States $0.371B 0.00
GH Research (GHRS) Ireland $0.369B 0.00
REGENXBIO (RGNX) United States $0.367B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.365B 0.00
Olema Pharmaceuticals (OLMA) United States $0.362B 0.00
Prime Medicine (PRME) United States $0.362B 0.00
Design Therapeutics (DSGN) United States $0.360B 0.00
Kamada (KMDA) Israel $0.348B 21.61
Absci (ABSI) United States $0.346B 0.00
Northwest Biotherapeutics (NWBO) United States $0.343B 0.00
Neurogene (NGNE) United States $0.336B 0.00
Sage Therapeutics (SAGE) United States $0.335B 0.00
Eton Pharmaceuticals (ETON) United States $0.330B 0.00
Tango Therapeutics (TNGX) United States $0.327B 0.00
Jasper Therapeutics (JSPR) United States $0.326B 0.00
Revance Therapeutics (RVNC) United States $0.322B 0.00
XOMA Royalty (XOMA) United States $0.320B 0.00
ACELYRIN, INC (SLRN) United States $0.318B 0.00
Voyager Therapeutics (VYGR) United States $0.316B 8.14
Corvus Pharmaceuticals (CRVS) United States $0.315B 0.00
Trevi Therapeutics (TRVI) United States $0.307B 0.00
Chimerix (CMRX) United States $0.300B 0.00
ATyr Pharma (ATYR) United States $0.287B 0.00
Candel Therapeutics (CADL) United States $0.286B 0.00
Prima BioMed (IMMP) Australia $0.284B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.282B 0.00
Lifecore Biomedical (LFCR) United States $0.280B 0.00
EnGene Holdings (ENGN) Canada $0.279B 0.00
Foghorn Therapeutics (FHTX) United States $0.279B 0.00
Atea Pharmaceuticals (AVIR) United States $0.275B 0.00
C4 Therapeutics (CCCC) United States $0.273B 0.00
ITeos Therapeutics (ITOS) United States $0.273B 0.00
Benitec Biopharma (BNTC) United States $0.269B 0.00
Artiva Biotherapeutics (ARTV) United States $0.266B 0.00
AC Immune (ACIU) Switzerland $0.265B 0.00
Rezolute (RZLT) United States $0.256B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.255B 0.00
Urogen Pharma (URGN) United States $0.254B 0.00
Abeona Therapeutics (ABEO) United States $0.247B 0.00
Fulcrum Therapeutics (FULC) United States $0.245B 0.00
Anika Therapeutics (ANIK) United States $0.239B 0.00
Precigen (PGEN) United States $0.230B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.229B 0.00
DiaMedica Therapeutics (DMAC) United States $0.225B 0.00
BioStem Technologies (BSEM) $0.220B 19.40
ProQR Therapeutics (PRQR) Netherlands $0.218B 0.00
BioAge Labs (BIOA) United States $0.218B 0.00
Nautilus Biotechnology (NAUT) United States $0.217B 0.00
Molecular Partners AG (MOLN) Switzerland $0.214B 0.00
Opthea (OPT) Australia $0.212B 0.00
Inhibrx Biosciences (INBX) United States $0.210B 0.00
Ocugen (OCGN) United States $0.209B 0.00
Compass Therapeutics (CMPX) United States $0.206B 0.00
Cardiff Oncology (CRDF) United States $0.200B 0.00
Mersana Therapeutics (MRSN) United States $0.200B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.196B 0.00
Gossamer Bio (GOSS) United States $0.191B 0.00
Fate Therapeutics (FATE) United States $0.189B 0.00
Inozyme Pharma (INZY) United States $0.188B 0.00
TuHURA Biosciences (HURA) United States $0.188B 0.00
Amarin (AMRN) Ireland $0.188B 0.00
Semper Paratus Acquisition (TVGN) United States $0.187B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.187B 0.00
GENFIT S.A (GNFT) France $0.183B 0.00
Alector (ALEC) United States $0.181B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.179B 0.00
Checkpoint Therapeutics (CKPT) United States $0.178B 0.00
Verastem (VSTM) United States $0.174B 0.00
Kyverna Therapeutics (KYTX) United States $0.171B 0.00
Innate Pharma S.A (IPHA) France $0.171B 0.00
Adherex Technologies (FENC) United States $0.170B 0.00
Coherus BioSciences (CHRS) United States $0.169B 0.00
ScPharmaceuticals (SCPH) United States $0.169B 0.00
Solid Biosciences (SLDB) United States $0.167B 0.00
Bright Minds Biosciences (DRUG) United States $0.167B 0.00
Nkarta (NKTX) United States $0.166B 0.00
Cidara Therapeutics (CDTX) United States $0.165B 0.00
Seres Therapeutics (MCRB) United States $0.164B 0.00
Renovaro (RENB) United States $0.163B 0.00
Ventyx Biosciences (VTYX) United States $0.161B 0.00
Greenwich LifeSciences (GLSI) United States $0.161B 0.00
Sutro Biopharma (STRO) United States $0.159B 0.00
2seventy Bio (TSVT) United States $0.156B 0.00
TScan Therapeutics (TCRX) United States $0.155B 0.00
Caribou Biosciences (CRBU) United States $0.153B 0.00
Sagimet Biosciences (SGMT) United States $0.152B 0.00
Zura Bio (ZURA) United States $0.151B 0.00
Elutia (ELUT) United States $0.149B 0.00
Puma Biotechnology (PBYI) United States $0.148B 6.29
Adaptimmune Therapeutics (ADAP) United Kingdom $0.148B 0.00
InflaRx (IFRX) Germany $0.148B 0.00
Actuate Therapeutics (ACTU) United States $0.147B 0.00
Biomea Fusion (BMEA) United States $0.145B 0.00
Instil Bio (TIL) United States $0.143B 0.00
Compugen (CGEN) Israel $0.143B 80.00
Aligos Therapeutics (ALGS) United States $0.141B 0.00
CAMP4 Therapeutics (CAMP) United States $0.139B 0.00
XBiotech (XBIT) United States $0.139B 0.00
Climb Bio (CLYM) United States $0.133B 0.00
Tenaya Therapeutics (TNYA) United States $0.132B 0.00
PepGen (PEPG) United States $0.131B 0.00
Seer (SEER) United States $0.130B 0.00
Abpro Holdings (ABP) United States $0.125B 0.00
Black Diamond Therapeutics (BDTX) United States $0.124B 0.00
Invizyne Technologies (IZTC) United States $0.122B 0.00
Akoya Biosciences (AKYA) United States $0.119B 0.00
Monopar Therapeutics (MNPR) United States $0.116B 0.00
Inventiva S.A (IVA) France $0.115B 0.00
Cabaletta Bio (CABA) United States $0.114B 0.00
Allakos (ALLK) United States $0.113B 0.00
TELA Bio (TELA) United States $0.113B 0.00
Leap Therapeutics (LPTX) United States $0.112B 0.00
Alto Neuroscience (ANRO) United States $0.110B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.108B 0.00
MediciNova (MNOV) United States $0.102B 0.00
BioHarvest Sciences (BHST) Canada $0.100B 0.00
Editas Medicine (EDIT) United States $0.100B 0.00
INmune Bio (INMB) United States $0.100B 0.00
Applied Therapeutics (APLT) United States $0.099B 0.00
X4 Pharmaceuticals (XFOR) United States $0.099B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.099B 0.00
Adverum Biotechnologies (ADVM) United States $0.099B 0.00
ALX Oncology Holdings (ALXO) United States $0.097B 0.00
Immunic (IMUX) United States $0.095B 0.00
HilleVax (HLVX) United States $0.093B 0.00
Genenta Science S.p.A (GNTA) Italy $0.091B 0.00
Coya Therapeutics (COYA) United States $0.090B 0.00
Nuvectis Pharma (NVCT) United States $0.090B 0.00
Cellectis S.A (CLLS) France $0.087B 0.00
Adagene (ADAG) China $0.086B 0.00
Adlai Nortye (ANL) Cayman Islands $0.085B 0.00
Theratechnologies (THTX) Canada $0.084B 0.00
CytomX Therapeutics (CTMX) United States $0.084B 6.29
Eupraxia Pharmaceuticals (EPRX) Canada $0.083B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.083B 0.00
23andMe Holding (ME) United States $0.083B 0.00
Genelux (GNLX) United States $0.083B 0.00
Rani Therapeutics Holdings (RANI) United States $0.081B 0.00
Scilex Holding (SCLX) United States $0.080B 0.00
FibroBiologics (FBLG) United States $0.080B 0.00
ZIVO Bioscience (ZIVO) United States $0.078B 0.00
Alpha Cognition (ACOG) Canada $0.078B 0.00
Entera Bio (ENTX) Israel $0.078B 0.00
Skye Bioscience (SKYE) United States $0.077B 0.00
Atara Biotherapeutics (ATRA) United States $0.077B 0.00
Bluebird Bio (BLUE) United States $0.076B 0.00
Adicet Bio (ACET) United States $0.076B 0.00
Quince Therapeutics (QNCX) United States $0.075B 0.00
Oncolytics Biotech (ONCY) Canada $0.075B 0.00
Aerovate Therapeutics (AVTE) United States $0.075B 0.00
Aadi Bioscience (AADI) United States $0.074B 0.00
Ikena Oncology (IKNA) United States $0.074B 0.00
I-Mab (IMAB) China $0.073B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.073B 0.00
Generation Bio (GBIO) United States $0.071B 0.00
VistaGen Therapeutics (VTGN) United States $0.071B 0.00
Clearside Biomedical (CLSD) United States $0.070B 0.00
Immuneering (IMRX) United States $0.070B 0.00
Annovis Bio (ANVS) United States $0.069B 0.00
Werewolf Therapeutics (HOWL) United States $0.069B 0.00
Ovid Therapeutics (OVID) United States $0.069B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.067B 0.00
Vigil Neuroscience (VIGL) United States $0.067B 0.00
BeyondSpring (BYSI) United States $0.066B 0.00
Galena Biopharma (SLS) United States $0.065B 0.00
Agenus (AGEN) United States $0.065B 0.00
Cue Biopharma (CUE) United States $0.064B 0.00
DBV Technologies S.A (DBVT) France $0.063B 0.00
BGM Group (BGM) China $0.062B 0.00
PDS Biotechnology (PDSB) United States $0.061B 0.00
Invivyd (IVVD) United States $0.061B 0.00
Rapt Therapeutics (RAPT) United States $0.060B 0.00
Vor Biopharma (VOR) $0.060B 0.00
Immix Biopharma (IMMX) United States $0.060B 0.00
IO Biotech (IOBT) Denmark $0.060B 0.00
Boundless Bio (BOLD) United States $0.058B 0.00
Repare Therapeutics (RPTX) Canada $0.057B 0.00
Kronos Bio (KRON) United States $0.057B 0.00
Elicio Therapeutics (ELTX) United States $0.057B 0.00
Connect Biopharma Holdings (CNTB) United States $0.055B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.053B 0.00
Shattuck Labs (STTK) United States $0.053B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.052B 0.00
Dyadic (DYAI) United States $0.051B 0.00
Spero Therapeutics (SPRO) United States $0.051B 13.39
Xilio Therapeutics (XLO) United States $0.051B 0.00
Celularity (CELU) United States $0.050B 0.00
Fortress Biotech (FBIO) United States $0.050B 0.00
Kezar Life Sciences (KZR) United States $0.048B 0.00
Inovio Pharmaceuticals (INO) United States $0.048B 0.00
Aileron Therapeutics (ALRN) United States $0.047B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.047B 0.00
Omega Therapeutics (OMGA) United States $0.046B 0.00
Exicure (XCUR) United States $0.045B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.045B 0.00
VTv Therapeutics (VTVT) United States $0.044B 0.00
Estrella Immunopharma (ESLA) United States $0.042B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.042B 0.00
Clene (CLNN) United States $0.042B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.041B 0.00
AN2 Therapeutics (ANTX) United States $0.041B 0.00
Q32 Bio (QTTB) United States $0.040B 0.00
Passage Bio (PASG) United States $0.040B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.040B 0.00
Lexaria Bioscience (LEXX) Canada $0.039B 0.00
CalciMedica (CALC) United States $0.038B 0.00
Enzo Biochem (ENZ) United States $0.038B 0.00
SAB Biotherapeutics (SABS) United States $0.038B 0.00
Grace Therapeutics (GRCE) Canada $0.037B 0.00
OKYO Pharma (OKYO) $0.036B 0.00
Rallybio (RLYB) United States $0.036B 0.00
Oncobiologics (OTLK) United States $0.035B 0.00
Precision BioSciences (DTIL) United States $0.035B 0.00
Lantern Pharma (LTRN) United States $0.034B 0.00
Elevation Oncology (ELEV) United States $0.033B 0.00
Opus Genetics (IRD) United States $0.033B 0.00
RenovoRx (RNXT) United States $0.031B 0.00
Beyond Air (XAIR) United States $0.030B 0.00
Medicus Pharma (MDCX) Canada $0.030B 0.00
BioAtla (BCAB) United States $0.030B 0.00
LakeShore Biopharma (LSB) China $0.030B 0.00
Promis Neurosciences (PMN) Canada $0.030B 0.00
Intensity Therapeutics (INTS) United States $0.029B 0.00
Forte Biosciences (FBRX) United States $0.029B 0.00
KALA BIO (KALA) United States $0.029B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
NKGen Biotech (NKGN) United States $0.028B 0.00
Cognition Therapeutics (CGTX) United States $0.027B 0.00
Curis (CRIS) United States $0.027B 0.00
OnKure Therapeutics (OKUR) United States $0.026B 0.00
Cadrenal Therapeutics (CVKD) United States $0.026B 0.00
Longeveron (LGVN) United States $0.026B 0.00
Lisata Therapeutics (LSTA) United States $0.026B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.026B 0.00
Cocrystal Pharma (COCP) United States $0.026B 0.00
Cara Therapeutics (CARA) United States $0.025B 0.00
Femasys (FEMY) United States $0.025B 0.00
Pluri (PLUR) Israel $0.025B 0.00
Chemomab Therapeutics (CMMB) Israel $0.025B 0.00
NextCure (NXTC) United States $0.024B 0.00
BRIACELL THERAP (BCTX) Canada $0.023B 0.00
Gelteq (GELS) Australia $0.023B 0.00
Equillium (EQ) United States $0.023B 0.00
HOOKIPA Pharma (HOOK) United States $0.023B 0.00
Pulmatrix (PULM) United States $0.022B 0.00
GeoVax Labs (GOVX) United States $0.021B 0.00
Athira Pharma (ATHA) United States $0.021B 0.00
MiNK Therapeutics (INKT) United States $0.021B 0.00
Bionano Genomics (BNGO) United States $0.021B 0.00
Ocean Biomedical (OCEA) United States $0.021B 0.00
Affimed (AFMD) Germany $0.020B 0.00
Bolt Biotherapeutics (BOLT) United States $0.020B 0.00
Tenax Therapeutics (TENX) United States $0.019B 0.00
Senti Biosciences (SNTI) United States $0.019B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.018B 0.00
Prana Biotechnology (ATHE) Australia $0.018B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.017B 0.00
Cyclo Therapeutics (CYTH) United States $0.017B 0.00
Aprea Therapeutics (APRE) United States $0.017B 0.00
IN8bio (INAB) United States $0.017B 0.00
UNITY Biotechnology (UBX) United States $0.017B 0.00
Spruce Biosciences (SPRB) United States $0.016B 0.00
Synlogic (SYBX) United States $0.016B 0.00
Cingulate (CING) United States $0.016B 0.00
Pieris Pharmaceuticals (PVLA) United States $0.016B 0.00
Aptose Biosciences (APTO) Canada $0.015B 0.00
HCW Biologics (HCWB) United States $0.015B 0.00
BioXcel Therapeutics (BTAI) United States $0.015B 0.00
BioAffinity Technologies (BIAF) United States $0.015B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.015B 0.00
MetaVia (MTVA) United States $0.014B 0.00
CervoMed (CRVO) United States $0.014B 0.00
Ensysce Biosciences (ENSC) United States $0.013B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.013B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Apollomics (APLM) United States $0.012B 0.00
Imunon (IMNN) United States $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Turnstone Biologics (TSBX) United States $0.010B 0.00
COSCIENS Biopharma (CSCI) Canada $0.010B 0.00
Mainz Biomed (MYNZ) Germany $0.010B 0.00
Aytu BioPharma (AYTU) United States $0.009B 0.00
BioCardia (BCDA) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Polyrizon (PLRZ) Israel $0.009B 0.00
Mustang Bio (MBIO) United States $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Evogene (EVGN) Israel $0.008B 0.00
Eyenovia (EYEN) United States $0.007B 0.00
Soligenix (SNGX) United States $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
GRI Bio (GRI) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Galecto (GLTO) Denmark $0.006B 0.00
Quantum Biopharma (QNTM) Canada $0.006B 0.00
Vincerx Pharma (VINC) United States $0.006B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Elevai Labs (ELAB) United States $0.006B 0.00
Edesa Biotech (EDSA) Canada $0.006B 0.00
Carmell (CTCX) United States $0.006B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.006B 0.00
Moleculin Biotech (MBRX) United States $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Portage Biotech (PRTG) $0.005B 0.00
Syros Pharmaceuticals (SYRS) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Evaxion Biotech (EVAX) Denmark $0.005B 0.00
Organovo Holdings (ONVO) United States $0.005B 0.00
Purple Biotech (PPBT) Israel $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Allarity Therapeutics (ALLR) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Dogwood Therapeutics (DWTX) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
NAYA Biosciences (NAYA) United States $0.003B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.003B 0.00
Pasithea Therapeutics (KTTA) United States $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
180 Life Sciences (ATNF) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Citius Oncology (CTOR) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.002B 0.00
Eterna Therapeutics (ERNA) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00